Publicaciones en las que colabora con Miguel Blanco Álvarez (10)

2016

  1. Increased Endothelial Progenitor Cell Levels are Associated with Good Outcome in Intracerebral Hemorrhage

    Scientific Reports, Vol. 6

2014

  1. Human recombinant glutamate oxaloacetate transaminase 1 (GOT1) supplemented with oxaloacetate induces a protective effect after cerebral ischemia

    Cell Death and Disease, Vol. 5, Núm. 1

2013

  1. Glutamate oxaloacetate transaminase: A new key in the dysregulation of glutamate in migraine patients

    Cephalalgia, Vol. 33, Núm. 14, pp. 1148-1154

  2. Hyperthermia in human ischemic and hemorrhagic stroke: Similar outcome, different mechanisms

    PLoS ONE, Vol. 8, Núm. 11

2012

  1. Glutamate Excitoxicity Is the Key Molecular Mechanism Which Is Influenced by Body Temperature during the Acute Phase of Brain Stroke

    PLoS ONE, Vol. 7, Núm. 8

  2. Increased levels of circulating endothelial progenitor cells in patients with ischaemic stroke treated with statins during acute phase

    European Journal of Neurology, Vol. 19, Núm. 12, pp. 1539-1546

  3. Temporal profile of molecular signatures associated with circulating endothelial progenitor cells in human ischemic stroke

    Journal of Neuroscience Research, Vol. 90, Núm. 9, pp. 1788-1793

2011

  1. Blood levels of glutamate oxaloacetate transaminase are more strongly associated with good outcome in acute ischaemic stroke than glutamate pyruvate transaminase levels

    Clinical Science, Vol. 121, Núm. 1, pp. 11-17

  2. CDP-choline treatment increases circulating endothelial progenitor cells in acute ischemic stroke

    Neurological Research, Vol. 33, Núm. 6, pp. 572-577

  3. Toll-like receptors 2 and 4 in ischemic stroke: Outcome and therapeutic values

    Journal of Cerebral Blood Flow and Metabolism, Vol. 31, Núm. 6, pp. 1424-1431